Liver Ultrasonographic Elastography

PROCEDURE3 trials

Sponsors

Northwestern University, M.D. Anderson Cancer Center, National Cancer Institute (NCI)

Conditions

Barrett EsophagusEsophageal AdenocarcinomaHepatocellular CarcinomaLiver and Intrahepatic Bile Duct CarcinomaNonalcoholic Steatohepatitis

Phase 2

Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study

Active, not recruitingNCT04550481

Northwestern UniversityHepatocellular Carcinoma, Nonalcoholic Steatohepatitis

Start: 2021-05-11End: 2026-09-30Target: 45Updated: 2026-01-21

Obeticholic Acid for Prevention in Barrett's Esophagus

RecruitingNCT04939051

National Cancer Institute (NCI)Barrett Esophagus, Esophageal Adenocarcinoma

Start: 2024-01-03End: 2027-09-01Target: 30Updated: 2026-04-03

Unknown Phase

Surveys, Blood Testing, and Fibroscan in Screening for Liver Fibrosis and Liver Cirrhosis

Active, not recruitingNCT04785534

M.D. Anderson Cancer CenterLiver and Intrahepatic Bile Duct Carcinoma

Start: 2020-12-22End: 2026-08-31Updated: 2025-10-14

Related Papers

NAFLD and NAFLD Related HCC: Emerging Treatments and Clinical Trials.

2025-01-019 citations

Prevalence of risk factors for liver fibrosis and associations of serum biomarkers with liver fibrosis in a Houston community clinic.

Journal of Clinical Oncology2023-06-01